MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why UFPT Stock surged +2.55% Today — RQD Quant Desk Flash
$293.30 +2.55% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $295.35
UFP Technologies Inc. (UFPT) earns a Roarable Rating of A- (Buy) with 81/100 RQD Confidence. High-quality cash engine (28% profit margin, 14% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE A- • BUY
Cap $2.27B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $295.35 (+0.70%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 17/20 (A-) • 15.2% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 81/100 (A-) historically ranked in the Top 8% of excess returns over the next 90 days (+8.4% avg 90D alpha vs SPY • 71.6% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • A-
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B+ · Rk A
Each axis scored 0–20
12M PRICE TARGET CONE+10.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for UFPT)Realized 20D OHLCV Swing Band: ±7%
Deterministic 5-Pillar Attribution (81/100 Composite)
🔍 WHY UFPT SCORES 81/100 (A-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (22% of score)
Altman Z-Score 8.31 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9
▲ #2 Bullish Driver: Cash Engine Quality+17/20 pts (21% of score)
SEC XBRL FY 2025 (10-K): 15.2% FCF Margin ($91.9M FCF) & 28.3% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning14/20 pts (-6 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-6 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B$288.97+0.9% Next Q
73
Q2 (-2Q)Grade B+$291.67+1.4% Next Q
76
Q3 (-1Q)Grade A-$295.78-0.8% Next Q
78
CurrentGrade A-$293.30+8.4% Hist 90D α
81
Trajectory: B (73) → A- (81)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the UFPT Bull Thesis Could Fail
Even with a 81/100 (A-) score, UFPT faces multiple-compression risk if 33.3x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) — any gross margin slip below 25.8% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($291.73) or 200D SMA ($249.26) invalidates the momentum regime and cuts Target Base ($323.66) toward Bear Floor ($240.51).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $UFPT• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “UFPT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why UFPT Stock surged +2.55% Today — RQD Quant Desk Flash
UFP Technologies Inc. (UFPT) surged +2.55% to $293.30, trading at 72% of its 52-week range ($173.86 – $338.71). High-quality cash engine (28% profit margin, 14% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 72% of its 52-week range ($173.86 – $338.71) with RSI-14 at 44 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±7% around $293.30 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable A- (Buy) backed by 28.3% gross margin and $91.9M annual free cash flow.
Live UFPT Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (UFPT Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
UFPT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +53.06%⚡ TESTING RESISTANCE
2026-10-30O $289.8H $293.3L $279.8C $293.3VOL 85.1K
RES: $298.5SUP: $278.1SMA50: $291.7SMA200: $249.3
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
UFPT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
25.7%/yr Implied 5Y Growth
vs. +19.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on UFPT today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for UFPT. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for UFPT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (UFPT)
Health Care Rank #15 of 1016
⚔️ INSP vs UFPT Full Matrix →
1. Head-to-Head Health Care Peer Comparison (UFPT vs. INSP, LMAT, XRAY, KMTS)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, UFP Technologies Inc. (UFPT) ranks #15 by composite RQD confidence (81/100, grade A-) and #238 by equity capitalization ($2.27B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. UFPT currently leads its immediate peer cohort in composite quantitative strength at 81/100 (A-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| UFPT
ACTIVE
UFP Technologies Inc. | A- | 81/100 | 33.3x | 28.3% | 13.9% | +2.55% | $2.27B | Benchmark Subject |
| INSP Inspire Medical Systems Inc. | C- | 61/100 | 14.2x | 85.4% | 6.0% | +0.30% | $2.06B | /insp-vs-ufpt → |
| LMAT LeMaitre Vascular Inc. | B | 74/100 | 33.8x | 71.5% | 14.7% | +2.90% | $1.95B | /lmat-vs-ufpt → |
| XRAY DENTSPLY SIRONA Inc. | D | 46/100 | — | 50.0% | -11.0% | +1.80% | $1.92B | /xray-vs-ufpt → |
| KMTS Kestra Medical Technologies Ltd. | D- | 43/100 | — | 51.4% | -35.0% | +2.48% | $1.82B | /kmts-vs-ufpt → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000914156In its most recent audited fiscal period (FY2025, filed 2025-12-31), UFP Technologies Inc. (UFPT) reported GAAP revenue of $602.8M (+19.5% vs. FY2024 revenue of $504.4M , and +50.7% cumulative change since FY2023) , GAAP net income of $68.3M, operating cash flow of $91.9M, and free cash flow of $91.9M (+61.4% YoY). On the balance sheet, UFPT closed FY2025 with $655.1M in total assets against $123.0M in total debt (Altman Z-Score: 8.31, Piotroski F-Score: 9/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $602.8M | $68.3M | $91.9M | $91.9M | $655.1M | $123.0M |
| FY2024 (FY) | 2024-12-31 | $504.4M | $59.0M | $66.6M | $56.9M | $629.0M | $176.9M |
| FY2023 (FY) | 2023-12-31 | $400.1M | $44.9M | $41.3M | $41.3M | — | — |
3. UFPT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs UFPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, UFP Technologies Inc. (NASDAQ: UFPT) is rated A- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 81/100 at a spot price of $293.30 (+2.55% 1D, market cap $2.27B). Pillar breakdown: Fundamental Cash Engine 17/20, Institutional 13F & Options Flow 14/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 17/20, and SEC Balance-Sheet Forensics 15/20. Across 1016 tracked Health Care issuers, UFPT ranks #15 in composite RQD confidence.
How does UFPT compare to INSP and LMAT in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), UFPT carries a Roarable A- (81/100 RQD), trailing P/E of 33.3x, gross margin of 28.3%, and ROIC of 13.9%. By comparison, INSP (Inspire Medical Systems Inc.) holds a C- grade (61/100 RQD, P/E 14.2x, ROIC 6.0%, cap $2.06B) and LMAT (LeMaitre Vascular Inc.) posts a B grade (74/100 RQD, P/E 33.8x, ROIC 14.7%, cap $1.95B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).
What are the biggest fundamental strengths and SEC risk factors for UFPT?
Per UFPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000914156), UFP Technologies Inc. generated $602.8M in revenue (+19.5% YoY), $68.3M in net income, and $91.9M in free cash flow against $655.1M in total assets and $123.0M in total debt. Key quantitative strengths: Strong cash generator (28% profit margin)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is UFPT trading relative to its 50-day, 200-day, and 52-week technical levels?
UFPT last traded at $293.30 (+2.55% on volume of 107,557 shares), positioning the stock +0.54% above its 50-day simple moving average ($291.73) and +17.67% above its 200-day simple moving average ($249.26). Across its 52-week range of $173.86 to $338.71, UFPT sits at the 72.5% percentile with a 14-day RSI of 44.0 (NEUTRAL RANGE) and an implied next-earnings move of ±7.0% ($272.77 to $313.83).
UFPT Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is UFPT stock moving today?
Why UFPT Stock surged +2.55% Today — RQD Quant Desk Flash. High-quality cash engine (28% profit margin, 14% return on capital) with steady institutional support.